Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
3.05
Dollar change
+0.10
Percentage change
3.39
%
IndexRUT P/E- EPS (ttm)-0.44 Insider Own22.29% Shs Outstand169.87M Perf Week-3.48%
Market Cap575.60M Forward P/E- EPS next Y-0.39 Insider Trans-0.08% Shs Float146.65M Perf Month-4.98%
Income-74.39M PEG- EPS next Q-0.10 Inst Own49.97% Short Float3.43% Perf Quarter19.61%
Sales12.99M P/S44.31 EPS this Y11.36% Inst Trans4.32% Short Ratio3.99 Perf Half Y37.39%
Book/sh0.64 P/B4.79 EPS next Y-0.51% ROA-43.56% Short Interest5.03M Perf Year28.69%
Cash/sh0.68 P/C4.45 EPS next 5Y- ROE-57.54% 52W Range1.69 - 3.64 Perf YTD22.00%
Dividend Est.- P/FCF- EPS past 5Y18.41% ROI-60.86% 52W High-16.21% Beta1.94
Dividend TTM- Quick Ratio6.69 Sales past 5Y55.33% Gross Margin89.03% 52W Low80.47% ATR (14)0.13
Dividend Ex-Date- Current Ratio6.69 EPS Y/Y TTM3.41% Oper. Margin-616.64% RSI (14)46.51 Volatility2.84% 4.16%
Employees73 Debt/Eq0.07 Sales Y/Y TTM-60.80% Profit Margin-572.81% Recom1.40 Target Price4.40
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-0.69% Payout- Rel Volume1.67 Prev Close2.95
Sales Surprise-43.56% EPS Surprise9.09% Sales Q/Q-77.09% EarningsMay 02 BMO Avg Volume1.26M Price3.05
SMA20-6.43% SMA501.38% SMA20024.38% Trades Volume2,110,522 Change3.39%
Date Action Analyst Rating Change Price Target Change
Feb-02-22Upgrade Jefferies Hold → Buy $5
Feb-25-21Initiated Jefferies Hold $5
Dec-17-20Initiated H.C. Wainwright Buy $10
Jul-27-20Resumed JMP Securities Mkt Outperform $10 → $8
Jul-24-20Downgrade Robert W. Baird Outperform → Neutral
May-19-20Upgrade Wedbush Neutral → Outperform
Mar-06-20Upgrade Chardan Capital Markets Neutral → Buy $5
Feb-20-20Initiated Robert W. Baird Outperform $8
Feb-05-20Upgrade JMP Securities Mkt Perform → Mkt Outperform $10
Oct-07-19Reiterated B. Riley FBR Buy $7 → $3
Jun-06-24 11:15AM
11:15AM
Jun-05-24 02:30AM
May-29-24 07:30AM
May-22-24 02:00AM
12:03PM Loading…
May-17-24 12:03PM
10:40AM
09:00AM
May-07-24 07:30AM
May-03-24 11:19AM
03:24AM
May-02-24 12:55PM
08:58AM
08:45AM
07:44AM
07:30AM Loading…
07:30AM
07:25AM
Apr-30-24 09:40AM
Apr-18-24 07:30AM
Apr-04-24 08:30AM
Mar-08-24 07:30AM
Mar-01-24 08:17AM
Feb-29-24 11:14PM
08:40AM
07:52AM
07:30AM
Feb-15-24 07:30AM
Jan-08-24 07:30AM
Nov-09-23 04:24PM
04:01PM
09:12AM Loading…
09:12AM
Nov-08-23 07:30AM
01:16AM
Nov-07-23 08:05AM
07:40AM
07:30AM
07:15AM
Oct-30-23 09:32AM
Oct-24-23 07:30AM
Oct-18-23 07:30AM
Oct-11-23 08:05AM
Sep-12-23 10:56AM
08:58AM
Sep-11-23 04:15PM
Sep-07-23 07:30AM
Aug-04-23 03:29PM
Aug-03-23 08:55AM
07:49AM
07:30AM
Jul-23-23 10:19AM
Jul-20-23 07:30AM
Jul-12-23 07:30AM
Jul-10-23 04:01PM
Jun-23-23 09:40AM
Jun-21-23 07:30AM
02:01AM
Jun-07-23 09:40AM
02:01AM
Jun-01-23 11:29AM
May-31-23 07:30AM
May-30-23 09:26AM
May-29-23 10:08AM
May-22-23 09:40AM
May-17-23 07:38AM
May-09-23 12:00PM
07:30AM
May-04-23 11:52PM
09:40AM
08:55AM
07:30AM
Apr-27-23 03:20AM
Apr-25-23 11:57AM
11:50AM
07:30AM
Apr-20-23 07:30AM
Apr-18-23 04:01PM
02:18PM
Apr-12-23 12:37PM
Apr-11-23 03:30PM
01:00PM
Apr-04-23 04:08PM
08:22AM
08:17AM
07:52AM
Mar-24-23 12:29PM
Mar-19-23 10:17AM
Mar-16-23 07:30AM
Mar-14-23 04:05PM
Mar-10-23 06:36PM
Mar-06-23 01:55AM
Mar-03-23 03:50AM
Mar-02-23 09:25AM
07:30AM
Feb-16-23 07:30AM
Feb-15-23 12:02PM
Feb-13-23 07:01AM
Feb-06-23 07:30AM
Jan-27-23 07:30AM
Jan-11-23 10:24PM
Jan-05-23 07:30AM
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McElhaugh Michael J.Interim President & CEOFeb 02 '24Sale2.3110,16423,5041,504,793Feb 05 07:54 PM
Sofia Michael J.Chief Scientific OfficerFeb 02 '24Sale2.319,98223,0831,485,121Feb 05 07:54 PM
HASTINGS DAVID CChief Financial OfficerFeb 02 '24Sale2.319,59322,184181,907Feb 05 07:54 PM
Sims KarenChief Medical OfficerFeb 02 '24Sale2.314,35810,078125,542Feb 05 07:55 PM